Keen Vision Acquisition Corporation Reports Q2 2026 Financial Results with Net Loss and Declining Assets

Keen Vision Acquisition Corporation (KVAC) reported its financial results for the second quarter of 2026, revealing a net loss of $20,121 for the three months ending June 30, 2026, compared to a net income of $558,055 for the same period in 2025. For the first half of 2026, the company recorded a net income of $71,966, a significant decrease from the $1,126,226 reported in the first half of 2025. The decline in profitability is attributed to a reduction in dividend income earned from investments held in the Trust Account, which fell to $442,106 in the first half of 2026 from $1,489,599 in the same period last year.

KVAC's total assets as of June 30, 2026, amounted to $13.48 million, a sharp decline from $57.04 million at the end of 2025. This decrease is primarily due to a significant reduction in cash and investments held in the Trust Account, which dropped from $57 million to $13.39 million. The company's current liabilities increased slightly to $4.72 million from $4.06 million, while the accumulated deficit grew to $7.62 million from $7.01 million at the end of the previous fiscal year.

In terms of operational developments, KVAC has been actively pursuing a business combination. The company entered into a non-binding letter of intent with a clinical-stage biopharmaceutical company in March 2024, focusing on innovative therapies. However, the company has faced challenges in finalizing this transaction, leading to multiple extensions of its business combination deadline. As of June 30, 2026, KVAC had extended its deadline to October 27, 2026, to complete a business combination, with the possibility of further extensions.

The company has also experienced changes in its shareholder structure, with 1,090,446 ordinary shares subject to possible redemption as of June 30, 2026, down from 4,822,346 shares at the end of 2025. This reduction reflects shareholder redemptions as the company navigates its business combination efforts. Additionally, KVAC's cash position remains precarious, with only $11,464 in cash available as of the end of the reporting period, raising concerns about its ability to continue operations without securing additional financing.

Looking ahead, KVAC's management has expressed uncertainty regarding its ability to complete a business combination by the extended deadline. The company has indicated that if it fails to do so, it may face liquidation, which would require redeeming all outstanding public shares. The ongoing geopolitical tensions and market conditions may further complicate its search for a suitable business combination target. As of now, KVAC's securities have been delisted from the Nasdaq and are trading on the over-the-counter market, which may impact its visibility and access to capital moving forward.